Clinical Outcomes in AD Clinical Trials

Video

Christopher G. Bunick, MD, PhD, provides an overview of clinical trial outcomes in atopic dermatitis (AD).

Related Videos
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
Related Content
Upadacitinib Led to Sustained, 140-Week Improvements for Atopic Dermatitis Patients

Upadacitinib Led to Sustained, 140-Week Improvements for Atopic Dermatitis Patients

Tim Smith
June 13th 2024
Article
A Patient-Centric Medcast on the Journey Through Moderate Plaque Psoriasis

A Patient-Centric Medcast on the Journey Through Moderate Plaque Psoriasis

Lauren Miller, MPAS, PA-C;Jayme M Heim, MSN, FNP-BC;Terry Faleye, MPAS, PA-C
February 28th 2024
Podcast
Moderate-to-Severe Alopecia Areata Patients More Likely Than Mild Cases to Develop Eczema

Moderate-to-Severe Alopecia Areata Patients More Likely Than Mild Cases to Develop Eczema

Tim Smith
June 12th 2024
Article
Practical Tips for Managing Actinic Keratosis with Photodynamic Therapy in the Clinic

Practical Tips for Managing Actinic Keratosis with Photodynamic Therapy in the Clinic

Raj Chovatiya, MD, PhD;Neal Bhatia, MD;Dawn Merritt, DO
November 27th 2023
Podcast
Candrice Heath, MD | Credit: Temple University

Report Details Racial/Ethnic Differences in Treatment Satisfaction, Provider Trust in Atopic Dermatitis

Patrick Campbell
June 12th 2024
Article
Eczema Patients Treated with Upadacitinib in Real World Setting See Significant Improvements

Eczema Patients Treated with Upadacitinib in Real World Setting See Significant Improvements

Tim Smith
June 11th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.